Bone Medical

Bone Medical was an Australian biopharmaceutical company focused on therapies for bone and joint diseases, particularly osteoporosis and osteoarthritis. The company was listed on the ASX under the ticker BNE and advanced an oral calcitonin product known as Capsitonin for osteoporosis, positioning it as a reformulation and development-stage asset. Historical company materials describe a pipeline centered on bone disease rather than a broad multi-platform technology base. Bone Medical later changed its corporate name to Botanix Pharmaceuticals, so the Bone Medical identity is no longer an active standalone operating company.